Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
Department of Life Sciences, Imperial College London, London SW7 2AZ, UK.
Nat Commun. 2016 Sep 19;7:12563. doi: 10.1038/ncomms12563.
α-synuclein (αS) is an intrinsically disordered protein whose fibrillar aggregates are the major constituents of Lewy bodies in Parkinson's disease. Although the specific function of αS is still unclear, a general consensus is forming that it has a key role in regulating the process of neurotransmitter release, which is associated with the mediation of synaptic vesicle interactions and assembly. Here we report the analysis of wild-type αS and two mutational variants linked to familial Parkinson's disease to describe the structural basis of a molecular mechanism enabling αS to induce the clustering of synaptic vesicles. We provide support for this 'double-anchor' mechanism by rationally designing and experimentally testing a further mutational variant of αS engineered to promote stronger interactions between synaptic vesicles. Our results characterize the nature of the active conformations of αS that mediate the clustering of synaptic vesicles, and indicate their relevance in both functional and pathological contexts.
α-突触核蛋白(αS)是一种无规则卷曲的蛋白质,其纤维状聚集物是帕金森病路易小体的主要成分。尽管 αS 的具体功能仍不清楚,但人们越来越认为它在调节神经递质释放过程中起着关键作用,这与突触小泡相互作用和组装的介导有关。在这里,我们报告了对与家族性帕金森病相关的野生型 αS 和两种突变变体的分析,以描述一种分子机制的结构基础,该机制使 αS 能够诱导突触小泡的聚集。我们通过合理设计和实验测试进一步突变的 αS 变体来促进更强的突触小泡之间的相互作用,为这种“双锚”机制提供了支持。我们的研究结果描述了介导突触小泡聚集的 αS 活性构象的性质,并表明它们在功能和病理环境中的相关性。